Logo of cellresLink to Publisher's site
Cell Res. 2011 Sep; 21(9): 1332–1342.
Published online 2011 Jul 12. doi:  10.1038/cr.2011.113
PMCID: PMC3193467

Lineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development


Methylation of cytosine is a DNA modification associated with gene repression. Recently, a novel cytosine modification, 5-hydroxymethylcytosine (5-hmC) has been discovered. Here we examine 5-hmC distribution during mammalian development and in cellular systems, and show that the developmental dynamics of 5-hmC are different from those of 5-methylcytosine (5-mC); in particular 5-hmC is enriched in embryonic contexts compared to adult tissues. A detectable 5-hmC signal appears in pre-implantation development starting at the zygote stage, where the paternal genome is subjected to a genome-wide hydroxylation of 5-mC, which precisely coincides with the loss of the 5-mC signal in the paternal pronucleus. Levels of 5-hmC are high in cells of the inner cell mass in blastocysts, and the modification colocalises with nestin-expressing cell populations in mouse post-implantation embryos. Compared to other adult mammalian organs, 5-hmC is strongly enriched in bone marrow and brain, wherein high 5-hmC content is a feature of both neuronal progenitors and post-mitotic neurons. We show that high levels of 5-hmC are not only present in mouse and human embryonic stem cells (ESCs) and lost during differentiation, as has been reported previously, but also reappear during the generation of induced pluripotent stem cells; thus 5-hmC enrichment correlates with a pluripotent cell state. Our findings suggest that apart from the cells of neuronal lineages, high levels of genomic 5-hmC are an epigenetic feature of embryonic cell populations and cellular pluri- and multi-lineage potency. To our knowledge, 5-hmC represents the first epigenetic modification of DNA discovered whose enrichment is so cell-type specific.

Keywords: epigenetics, 5-hydroxymethylcytosine, 5-methylcytosine, CpG-methylation, stem cells, mammalian development, pluripotency


The methylation of cytosines in a CpG context is a common modification in mammalian genomes, and is generally associated with gene repression in vivo and in vitro 1. Alteration of 5-methylcytosine (5-mC) patterns during development contributes to the regulation of gene expression and cell specification 1, 2, 3. In addition to 5-mC, a novel cytosine modification, 5-hydroxymethylcytosine (5-hmC), has recently been found in mouse brain and murine embryonic stem cells (mESCs) 4, 5. The conversion of 5-mC to 5-hmC is catalysed by Tet (Ten-eleven translocation) oncogene family member proteins 4, 6. Notably, as 5-hmC is interpreted as 5-mC in bisulphite sequencing 7, 8, 9, 10, the routine method of mC identification, these two cytosine modifications are indistinguishable from each other in the vast majority of currently available experimental results. Therefore, there is a need to re-evaluate many DNA methylation data, taking into account the existence of this novel cytosine modification with its (probable) distinct functional role. Since it has been already reported that methyl-CpG binding proteins do not interact with 5-hmC-containing DNA substrates 7, 11, these two modifications are likely to play distinct roles in biological systems. Although a recent report suggested the importance of Tet1 in mESC self-renewal and inner cell mass (ICM) specification in early embryos 6, the biological functions and developmental distribution of genomic 5-hmC levels have not been studied. Here we assessed 5-hmC distribution throughout mammalian development, and in adult tissues in vivo and in in vitro cell systems using immunochemical methods.


Genomic 5-hmC is enriched in embryonic and induced pluripotent stem cells compared to differentiated cells

We used two commercially available anti-5-hmC antibodies produced by Diagenode and Active Motif for our analysis. Since the Diagenode antibody has not been characterised in immunochemistry previously, we first confirmed its specificity in dot blot assays using PCR-produced DNA fragments with all of the cytosines replaced by either 5-hmC or 5-mC, and total genomic human ESC and human dermal fibroblast (HDF) DNA (Supplementary information, Figure S1A). The anti-5-hmC antibody specifically recognised the 5-hmC-enriched PCR fragment and hESC genomic DNA, but not 5-mC-containing or unmodified PCR fragments or HDF DNA. The dot blot assay exhibited relatively low sensitivity, and only the equivalent of 500 ng of total genomic DNA produced a detectable signal with the anti-5-hmC antibody. Since the estimated genomic proportion of 5-hmC in mESCs is relatively low (<1% total cytosine content) 4, we used a peroxidase-conjugated secondary antibody coupled with a tyramide signal enhancement system for 5-hmC detection in subsequent immunochemical staining experiments. Under these conditions, the anti-5-hmC antibody produced distinctive nuclear staining patterns on mESCs and hESCs (Figure 1A and Supplementary information, Figure S1B), but not on human and mouse cancer and immortalised cell lines (Supplementary information, Figure S1C). These results were consistent with previously reported data obtained by thin layer chromatography (TLC) 4, 5 and with our dot blot results (Supplementary information, Figure S1A). We obtained essentially identical results using the Active Motif anti-5-hmC antibody, which has been successfully used in dot blots, immunochemistry and other applications previously 6, 9, 12, 13. In our experiments 5-hmC was strongly enriched in hESCs, compared to a very weak 5-hmC signal in HDFs (Supplementary information, Figure S2). Both antibodies also behaved similarly in all further experiments. We concluded that the Diagenode anti-5-hmC antibody specifically recognises 5-hmC, but not 5-mC, in immunocytochemical assays. Notably, the distribution of 5-hmC staining in ESCs was strikingly different from that of 5-mC. The intensity of the 5-hmC signal was strong in the cells forming the colonies of ESCs, and was considerably weaker in surrounding differentiating fibroblast-like “stromal” cells, whereas 5-mC was detectable in both cell types at similar levels (Figure 1B and Supplementary information, Figure S1D). This is consistent with the observation that 5-hmC content decreases upon differentiation of murine ESCs, as reported previously 4, 14. We decided to examine the dynamics of this process using a protocol to differentiate hESCs to hepatic endoderm 15. The 5-hmC signal dropped significantly following a 3-day treatment with Wnt3A and Activin to induce definitive endoderm, and was virtually undetectable after an additional 2 days of differentiation (Figure 1C). Concurrent analysis of transcriptome changes by global quantitative deep sequencing revealed a parallel reduction in the number of Oct4 and Nanog transcripts (Figure 1D). Unexpectedly, we observed an increase in the numbers of transcripts of all three Tet genes at 3 days post-induction at the time point where the 5-hmC signal dropped significantly (Figure 1D). Possible explanations for this discrepancy include the presence of mechanisms regulating Tet proteins at either the post-transcriptional/post-translational levels, or the inhibition of their oxygenase enzymatic activity. Over 5 days of differentiation, the numbers of Tet1, Tet2 and Tet3 transcripts also decreased (Figure 1D). To determine the correspondence of 5-hmC with acquisition of a pluripotent state we carried out 5-hmC immunostaining on human induced pluripotent stem cells (iPSCs) 16 and their parental somatic cell lines. hiPSC lines generated from both normal and Huntington's disease tissues (Supplementary information, Figure S3), but not from their parental HDFs, exhibited a strong 5-hmC signal (Figure 1E and Supplementary information, Figure S1D). In summary, our screening of in vitro cell systems for the presence of immunochemically detectable levels of 5-hmC revealed a strong correlation of high levels of this modification with a pluripotent stem cell state.

Figure 1
The presence of immunochemically detectable 5-hydroxymethylcytosine (5-hmC) levels correlates with pluripotency in mammalian cells. 5-hmC is detectable in mouse and human (RH1 and RCM1) ESCs. (A) Lines stained with 5-hmC antibody. (B) 5-hmC and 5-mC staining ...

Global hydroxymethylation of the paternal genome coincides with the loss of 5-methylcytosine signal in zygote

Several hours after fertilisation, chromatin of both maternal and paternal pronuclei of the mammalian zygote is subjected to extensive genome-wide reprogramming as the embryo makes a transition from a germ cell to a somatic developmental programme 2, 17. One notable reprogramming event is a dramatic loss of the 5-mC signal detectable by immunochemistry only in the paternal pronucleus after fertilisation 18. It has been suggested that conversion of 5-mC to 5-hmC may represent an intermediate step in the process of cytosine demethylation 4. In agreement with a recent study 19, we could not detect any 5-hmC staining in the embryos before 2.5 h post-fertilisation, when a weak 5-hmC signal started to appear in the paternal pronucleus (Figure 2A, PN1-2, PN2-3). The intensity of the 5-hmC signal increased dramatically during the next 2 h (Figure 2A, PN3-4, PN4), peaking at 5-8 h post-fertilisation (Figure 2A, PN5, syngamy) coincident with a significant decrease and subsequent loss of 5-mC staining in the male pronucleus. The majority of embryos exhibited a strong 5-hmC signal, exclusively in the paternal pronucleus, whereas the maternal pronuclear 5-hmC staining was weak or undetectable (Figures 2A, Supplementary information, S4A, S4B). This corresponded to a strong 5-mC signal in the maternal pronucleus and its loss in the paternal pronucleus. Some embryos (11.4% at PN4-5) showed comparable levels of strong 5-hmC staining in both male and female pronuclei concurrently with equally low or absent 5-mC signals in both pronuclei (Supplementary information, Figure S4A, S4B). Nonparametric statistical analysis showed a significant negative correlation (r = −0.9834, p < 0.0001) between 5-hmC and 5-mC immunostaining scores (Supplementary information, Figure S4A-S4C), suggesting that a decrease in 5-mC staining intensity is related to an increase in 5-hmC content in the mouse zygote at PN4-5. This most likely represents genome-wide 5-mC conversion into 5-hmC. Since 5-hmC is not detectable using an anti-5-mC antibody 4 and accumulates in the paternal genome at significant levels during the embryo's first cell cycle, together with a previous report, 19 these results suggest that the loss of 5-mC signal in the zygote at least partially represents a consequence of genome-wide 5-mC conversion into 5-hmC. 5-hmC-Independent demethylation of several genes has indeed been detected using bisulphate sequencing in the zygote 20, but bisulphite sequencing has never been performed on a genome-wide scale in preimplantation embryos. It is most likely that hydroxylation-independent demethylation of certain genome regions and global 5-mC hydroxylation occurs simultaneously in mouse embryos after fertilisation.

Figure 2
5-Hydroxymethylcytosine (5-hmC) distribution in mouse pre-implantation development. (A) Distribution of 5-hmC and 5-mC during indicated pronuclear stages in mouse zygote. Merged and phase views, where pronuclei are distinguishable at PN3-PN4 stages, are ...

High levels of 5-hmC colocalise with the ICM in blastocysts and with nestin-expressing cell populations in post-implantation mouse embryos

To determine the dynamics of 5-hmC content in later mammalian development, we carried out whole-mount immunostaining of pre-implantation and sections of post-implantation mouse embryos. A detectable 5-hmC signal was present throughout all the stages of pre-implantation development, slightly decreasing by the 8-cell stage (Figure 2B). Strong 5-hmC staining started to appear at the morula stage and was observed in mouse blastocysts with the maximum signal intensity in the ICM (Figure 2B and Supplementary information, Figure S5A). In contrast, the 5-mC signal showed less perceptible variation between the ICM and trophoblast cells of blastocysts than did the 5-hmC signal (Figure 2B and Supplementary information, Figure S5B).

The 5-hmC enrichment in the ICM of mouse blastocysts is consistent with our immunochemical detection of 5-hmC in mESCs and previous TLC data 4, 5. It is also consistent with the expression of Tet proteins in both mESCs and the blastocyst ICM 4, 6. Interestingly, the study of murine post-implantation embryos revealed a pattern of regional enrichment of 5-hmC nuclear staining correlated with the presumptive location of multi-potent progenitor or stem cells, becoming increasingly restricted with development (Figure 3A). At 10.5 days post-coitum (dpc) most embryonic tissues were highly enriched for 5-hmC (Figure 3A). At 12.5 dpc, mouse embryos exhibited intense 5-hmC staining in a range of embryonic tissues. Significantly higher levels of 5-hmC were observed in the brain, spinal cord, tailbud and liver but not in heart, skin or mesenchymal tissue (Figure 3A and and3B,3B, Supplementary information, Figure S5C-S5G, Figure 4A-4D). By 15.5 dpc, 5-hmC staining was generally less intense and limited to the brain and peripheral neural tissue (Figure 3A and and3B).3B). According to 5-hmC signal quantification, the intensity of 5-hmC staining gradually decreased in brain tissue over time and fell dramatically in embryonic tongue between 12.5 dpc and 15.5 dpc (Figure 3B and and3C).3C). Whereas high levels of 5-hmC were detected in most of the cells of embryonic tongue at 10.5 dpc and 12.5 dpc, 5-hmC distribution in this organ at 15.5 dpc was limited to certain cell populations (Figure 3B). As expected, over the same period of development, the global level of DNA methylation was not restricted to any particular embryonic cell populations and did not vary significantly between embryonic stages (Supplementary information, Figures S5C-S5G, S6).

Figure 3
The dynamics of 5-hydroxymethylcytosine (5-hmC) in mouse post-implantational embryonic development. (A) Sagital sections of 10.5 days post coitum (dpc), 12.5 dpc and 15.5 dpc mouse embryos stained with Diagenode antibody to 5-hmC. Immunostaining for single-stranded ...
Figure 4
5-Hydroxymethylcytosine (5-hmC) localises with nestin-expressing stem cell populations in 12.5 dpc mouse embryos. (A) Sagital section of 12.5 dpc mouse embryo with DNA visualised and B, C, D, E and F views indicated with dotted squares. Immunohistochemical ...

To identify these 5-hmC-rich cell populations, we performed immunostaining for nestin, an established marker of multi-potent progenitors and stem cells 21, 22, in 12.5 dpc mouse embryos. Adjacent serial sections were used for nestin and 5-hmC or 5-mC staining, as immunodetection of 5-hmC and 5-mC requires treatment of tissues with 4 N HCl, which is incompatible with the preservation of most protein epitopes. We observed that nestin staining closely correlates with the intense 5-hmC signal in brain, peripheral neural tissue and the tailbud, suggesting that a high genomic content of 5-hmC is a feature of nestin-expressing multi-potent fetal cells (Figure 4E and and4F).4F). Consistent with our observed association of high levels of 5-hmC with multi-lineage potency, we also observed a highly localised 5-hmC signal in the olfactory epithelium of 17.5 dpc mouse embryos (Supplementary information, Figure S7). The olfactory epithelium is known to contain multi-potent stem cells constantly differentiating into supporting and olfactory cells in the embryo and adult 23.

The presence of high 5-hydroxymethylcytosine levels is restricted to neuronal tissue and bone marrow in adult human and mouse

Finally, we evaluated adult murine and human tissues for genomic 5-hmC distribution. In agreement with previously reported data obtained by TLC 5, we could not detect any significant 5-hmC signal in mouse liver, skin, ovary, spleen or heart (Supplementary information, Figure S8), nor in any human tissue tested, except for brain and bone marrow (Figure 5 and Supplementary information, Figure S9). In mouse brain, strong 5-hmC nuclear staining was found not only in the hippocampal region and subventricular zone, which have previously been reported as regions of active neurogenesis containing populations of neural stem cells (NSCs) and neural progenitors 24, 25, 26, 27, 28, but also in the neuronal tissue of the cortex and other parts of the brain and cerebellum (Figure 6A-6C, Supplementary information, Figure S8B). In particular, in the hippocampus, higher levels of 5-hmC were observed in the dentate gyrus than the adjacent pyramidal layer (Figure 6A), but this difference may be due to the relatively higher cell density of the former. Brain white matter did not display an intense 5-hmC signal (Figure 6A, ,6B6B and Supplementary information, Figure S8B). Consistent with these results and in agreement with already published data 29, NSC derived in vitro from hESCs also exhibit strong 5-hmC staining, which does not disappear or decline after 18 days of neuronal differentiation (Figure 6D and and6E),6E), but differentiation of progenitors towards oligodendrocyte lineages is characterised by the progressive loss of 5-hmC staining (data not shown). Notably, the transcripts of all 3 Tet genes are highly expressed in human NSCs, which make them distinct from human ES cells where only Tet1 and Tet3 transcripts are present at significant levels (Figure 6F).

Figure 5
The presence of immunochemically detectable 5-hydroxymethylcytosine (5-hmC) levels is restricted to bone marrow and neuronal tissues in adult mammals. A range of indicated normal adult human tissues from a Folio histological tissue array were immunostained ...
Figure 6
5-Hydroxymethylcytosine (5-hmC) is dramatically enriched in both neuronal progenitors and differentiated post-mitotic cells of neuronal lineages. (A) 5-hmC Is visualised by immunochemistry in hippocampal A and ventricular (B) regions of mouse brain and ...


Our study shows a correlation between high levels of genomic 5-hmC and multi-lineage-potential during mammalian development and in a number of adult tissues. High 5-hmC level is a feature of induced or embryonic pluripotent stem cells. Nestin-expressing fetal stem cells in post-implantation development, and stem cell-rich tissues including adult bone marrow and nasal epithelium of the late development mouse embryo also exhibit high 5-hmC levels, whereas the actively proliferating unipotent cells of adult mammalian skin or liver do not. Sometimes it appears that a strong 5-hmC signal coincides with stronger DNA staining (SVZ, olfactory epithelium), but it is worth noting that a higher DNA content is an expected feature of some rapidly proliferating stem cell populations, wherein a significant proportion of cells is present in the S-phase of the cell cycle. A more detailed analysis will be required to determine if high 5-hmC is being utilised by other adult tissue-specific stem cells. According to our study, neuronal lineages seem to be exceptional in their maintenance of high 5-hmC levels in differentiated, post-mitotic cells. In agreement with this finding it has been previously reported that differentiation of mESCs into neuronal progenitors and subsequently into mature neurons has been shown to be accompanied by relatively few changes in DNA methylation, most of which occur during the first stage of differentiation 30, 31. Thus, neurons may represent a unique mammalian post-mitotic differentiated cell type, with a chromatin organisation similar in some aspects (5-hmC enrichment) to that of stem cells. Our analysis of 5-hmC distribution in adult mouse tissues is supported by other reports on 5-hmC tissue quantification showing that 5-hmC is strongly enriched in the central nervous system, compared to other adult organs 5, 12, 14. Our data are also generally in agreement with TLC-based data 5, an isotope-based chromatographic method for quantification of 5-hmC 12, and with immunolocalisation of 5-hmC in mouse brain presented in the same study 12. In contrast to Globisch and colleagues, our results do not reveal immunochemically detectable 5-hmC in adult mouse liver and kidney, but the resolution of the corresponding figures in that report does not allow us to draw conclusions on the specificity of the observed staining in these tissues. It is also important to note that there is a slight discrepancy between the study of enzymatic quantification of genomic 5-hmC 14, where its levels in mouse lung and, especially, in kidney were similar to those in brain, and both our immunochemical data and the other published data, based on biochemical methods 5, 12, where the 5-hmC content of lung and kidney was reported to be much lower than that of neural tissues. It is possible that these differences stem from the nature and sensitivity of the methods used to quantify genomic 5-hmC in the corresponding reports.

Previous studies have established that 5-mC- and 5-hmC-containing DNAs have different protein binding properties; for example, the interaction of MBD proteins with 5-mC is abolished by hydroxymethylation 7, 11. This implies that these two epigenetic modifications perform distinct biological functions. It is possible that an elevated genomic content of 5-hmC could contribute both to the general “openness” of the chromatin in stem cell and neuronal nuclei, and to the regulation of expression of specific target genes during stem cell self renewal and differentiation. Further work is necessary to reveal the identity and roles of any 5-hmC binding proteins, and identify genes affected by hydroxymethylation of cytosine residues in tissue-specific contexts.

In conclusion, we show that unlike 5-mC, genomic 5-hmC is significantly enriched in embryonic contexts, cells with multi-lineage potency and neurons in mammals (Figure 7). To our knowledge, 5-hmC is the first epigenetic modification shown to possess such a cell-type-specific enrichment in its distribution.

Figure 7
A graphical summary illustrating 5-hydroxymethylcytosine (5-hmC) distribution in mammalian development. High levels of 5-hmC are marked with green shading.

Materials and Methods

ES cell culture and iPSC generation

RH1 and RCM1 hESCs have been described previously 32, 33. Mouse HM1 ESCs were maintained on gelatin-coated dishes in Glasgow's Minimum Essential medium (GIBCO), supplemented with 15% fetal bovine serum, 55 μM β-mercaptoethanol (GIBCO), 2 mM l-glutamine, 0.1 mM MEM non-essential amino acids, 5 000 units ml−1 penicillin/streptomycin and 1 000 units ml−1 of murine LIF (Chemicon) under feeder-free conditions. hESCs and hiPSCs were cultured on matrigel-coated plates and slides in feeder-free mTeSR1 medium (STEMCELL Technologies). Cells were passaged using collagenase IV (200 units ml−1 in DMEM, GIBCO) and mechanical dissociation. hESC differentiation to hepatic endoderm was performed according to the published protocol 15. hiPSCs were produced as described previously 16 and validated by flow cytometry, embryoid body formation, differentiation into endoderm, mesoderm and ectoderm and RT-PCR as described 32.

Immunocytochemistry, immunohistochemistry, pre-implantation embryo culture, imaging and dot blot assay

For immunocytochemistry, cells were fixed in 4% formaldehyde for 15 min. Paraffin-embedded formaldehyde-fixed sections of wild-type CD1 mouse embryos and adult tissues were used for immunohistochemistry. A normal human tissue histological array (Folio) was used for 5-hmC detection in human tissues. Tissue sections were de-waxed according to standard procedures. Cells and tissue sections were permeabilised for 15 min with PBS containing 0.5% Triton X-100. For 5-hmC and 5-mC staining, permeabilised cells and tissue sections were incubated in 4 N HCl for 1 h at 37 °C and then neutralised in 100 mM Tris-HCl (pH 8.5) for 10 min, followed by a standard immunostaining protocol.

Anti-5-hmC (Diagenode, 1:1 000 dilution; Active Motif, 1:5 000; 1:50 000 dilutions), anti-5-mC (Eurogentec) and anti-nestin clone 401 (DSHB) primary antibodies were used. DNA was visualised using an anti-single-stranded DNA antibody (Zymo research). Peroxidase-conjugated anti-rat secondary antibody (Dako) and the tyramide signal enhancement system (Perkin Elmer) were employed for 5-hmC detection.

Mouse embryos were produced by mating superovulated F1 females with CD1 males, and cultured according to standard procedures. Anti-5-hmC (Active Motif, 1:5 000 dilution) and anti-5-mC (Eurogentec, 1:200 dilution) antibodies were used for immunochemistry. Pre-implantation embryos were immunostained as described 34 with the use of peroxidase-conjugated secondary antibody and the additional tyramide (Perkin-Elmer) signal enhancement step for 5-hmC staining. Control staining without primary antibody produced no detectable signal. Images were acquired using a Zeiss Axiovert 200 immunofluorescence microscope and Axiovision software. Dot blot assays were performed as reported previously 10.

Image quantification

Image quantification was performed using Fiji software. Corresponding slides were processed in identical conditions and were imaged at the same exposure settings. Mean intensities were measured for 10 random squares on each region of interest for each sample. The 5-hmC signal was standardised to the total DNA signal. Mean values of the mean intensities are presented. Experimental error is expressed as s.e.m.

Statistical analysis

We used a numerical grading system 0 (absent), 1 (low) and 2 (high) to account for differences in 5-hmC and 5-mC staining intensities in maternal and paternal pronuclei of the mouse zygotes (the examples of the categories are arrowed on Supplementary information, Figure S4A). The statistical analysis was performed using GraphPad Prism software. The individual 5-hmC and 5-mC immunostaining scores (total number of xy pairs = 70) of both maternal (n = 35) and paternal pronuclei (n = 35) were correlated using Spearman's nonparametric test. The P value was considered significant for P < 0.05.

Solexa deep sequencing

Total RNA was isolated from hESCs at the times indicated after induction of differentiation and sequenced directly using a Solexa 1G system. The Solexa results were normalised as follows: the raw count reads of each gene were first divided by the total number of aligned reads multiplied by 1 million to take into account the depth of sequencing. The results were then divided by the length of each gene multiplied by 1 000 to get an RPKM value (read per kilo bases per million reads).

Neural stem cells

Neural stem cells were generated from p57 H9 hESCs and cultured as described 35. NSCs' identity was confirmed by immunostaining for Pax6, Sox2, Sox1 and Nestin. H9 hESCs were cultured on Matrigel with TeSR2 (STEMCELL Technologies) medium. Differentiation was performed in Neurobasal medium (N2 supplement 1:100).

Real time RT-PCR

Total RNA was extracted with TriReagent (Sigma). Samples were reverse transcribed using random primers (Promega) and Superscript II RT (Invitrogen). Products were detected using SYBR Green PCR Mastermix (Applied Biosystems) and a PTC-200 cycler with a Chromo-4 detection system (MJ Research). Data were normalised with relative to GAPDH. Error is expressed as s.e.m. Primer sequences for human Tet proteins are available upon request.

Immunostaining competition experiment

Immunostaining competition experiments were performed as described 12 using PCR-produced 100-bp DNA fragments, where all the cytosines were replaced with either 5-hmC or 5-mC.


We thank Adrian Bird (University of Edinburgh) for encouragement, Paz Freile, Sebastian Greenhough, Sharmin Haideri, Heidi Mjoseng, Jane Taylor (MRC Centre for Regenerative Medicine, University of Edinburgh) and Britt Tye (Roslin Cells) for technical support; the Histology team of MRC Human Reproductive Sciences Unit for excellent service and John Iredale (MRC Centre for Regenerative Medicine, University of Edinburgh) for access to Solexa data. DH is an RCUK fellow.


(Supplementary information is linked to the online version of the paper on the Cell Research website.)

Supplementary Information

Supplementary information, Figure S1

Supplementary information, Figure S2

5-hmC detection in human ESCs (RH1) and human dermal fibroblasts (HDFs) using a 5-hmC antibody produced by Active Motif.

Supplementary information, Figure S3

hiPSC validation.

Supplementary information, Figure S4

Supplementary information, Figure S5

Immunochemistry on mouse blastocysts performed using anti-5-hmC antibody produced by Diagenode.

Supplementary information, Figure S6

Supplementary information, Figure S7

Lateral section of the nasal cavity region of a mouse 17.5 dpc embryo showing the olfactory epithelial tissue stained with anti-5-hmC antibody.

Supplementary information, Figure S8

Supplementary information, Figure S9

Related to figure 5.

Supplementary information, Data S1

Supplementary Experimental Procedures


  • Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16:6–21. [PubMed]
  • Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science. 2001;293:1089–1093. [PubMed]
  • Surani MA, Hayashi K, Hajkova P. Genetic and epigenetic regulators of pluripotency. Cell. 2007;128:747–762. [PubMed]
  • Tahiliani M, Koh KP, Shen Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324:930–935. [PMC free article] [PubMed]
  • Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science. 2009;324:929–930. [PMC free article] [PubMed]
  • Ito S, D'Alessio AC, Taranova OV, et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature. 2010;466:1129–1133. [PMC free article] [PubMed]
  • Jin SG, Kadam S, Pfeifer GP. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res. 2010;38:e125. [PMC free article] [PubMed]
  • Hayatsu H, Shiragami M. Reaction of bisulfite with the 5-hydroxymethyl group in pyrimidines and in phage DNAs. Biochemistry. 1979;18:632–637. [PubMed]
  • Huang Y, Pastor WA, Shen Y, et al. The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One. 2010;5:e8888. [PMC free article] [PubMed]
  • Nestor C, Ruzov A, Meehan R, Dunican D. Enzymatic approaches and bisulphite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA. Biotechniques. 2010;48:317–319. [PubMed]
  • Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2) Nucleic Acids Res. 2004;32:4100–4108. [PMC free article] [PubMed]
  • Globisch D, Münzel M, Müller M, et al. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS One. 2010;5:e15367. [PMC free article] [PubMed]
  • Ko M, Huang Y, Jankowska AM, et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature. 2010;468:839–843. [PMC free article] [PubMed]
  • Szwagierczak A, Bultmann S, Schmidt CS, Spada F, Leonhardt H. Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res. 2010;38:e181. [PMC free article] [PubMed]
  • Hay DC, Fletcher J, Payne C, et al. Highly efficient differentiation of hESC to functional hepatic endoderm requires ActivinA and Wnt3a signalling. Proc Natl Acad Sci USA. 2008;105:12301–12306. [PMC free article] [PubMed]
  • Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–872. [PubMed]
  • Feng S, Jacobsen SE, Reik W. Epigenetic reprogramming in mammalian development. Science. 2010;330:622–627. [PMC free article] [PubMed]
  • Mayer W, Niveleau A, Walter J, Fundele R, Haaf T. Demethylation of the zygotic paternal genome. Nature. 2000;403:501–502. [PubMed]
  • Iqbal K, Jin SG, Pfeifer GP, Szabó PE. Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc Natl Acad Sci USA. 2011;108:3642–3647. [PMC free article] [PubMed]
  • Oswald J, Engemann S, Lane N, et al. Active demethylation of the paternal genome in the mouse zygote. Curr Biol. 2000;10:475–478. [PubMed]
  • Wislet-Gendebien S, Wautier PF, Leprince B. Astrocytic and neuronal fate of mesenchymal stem cells expressing nestin. Brain Res Bull. 2005;68:95–102. [PubMed]
  • Wiese C, Rolletschek A, Kania G, et al. Nestin expression-a property of multi-lineage progenitor cells. Cell Mol Life Sci. 2004;61:2510–2522. [PubMed]
  • Murrell W, Féron F, Wetzig A, et al. Multipotent stem cells from adult olfactory mucosa. Dev Dyn. 2005;233:496–515. [PubMed]
  • Merkle FT, Tramontin AD, Garcia-Verdugo JM, Alvarez-Buylla A. Radial glia give rise to adult neural stem cells in the subventricular zone. Proc Natl Acad Sci USA. 2004;101:17528–17532. [PMC free article] [PubMed]
  • Merkle FT, Alvarez-Buylla A. Neural stem cells in mammalian development. Curr Opin Cell Biol. 2006;18:704–709. [PubMed]
  • Doetsch F, Caille I, Lim DA, García-Verdugo JM, Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell. 1999;97:703–716. [PubMed]
  • Seri JM, García-Verdugo BS, McEwen A, Alvarez-Buylla A. Astrocytes give rise to new neurons in the adult mammalian hippocampus. J Neurosci. 2001;21:7153–7160. [PubMed]
  • Deng W, Aimone JB, Gage FH. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory. Nat Rev Neurosci. 2010;11:339–350. [PMC free article] [PubMed]
  • Song CX, Szulwach KE, Fu Y, et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat Biotechnol. 2011;29:68–72. [PMC free article] [PubMed]
  • Meissner A, Mikkelsen TS, Gu H, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature. 2008;454:766–770. [PMC free article] [PubMed]
  • Mohn F, Weber M, Rebhan M, et al. Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol Cell. 2008;30:755–766. [PubMed]
  • Fletcher JM, Ferrier PM, Gardner JO, et al. Variations in humanized and defined culture conditions supporting derivation of new human embryonic stem cell lines. Cloning Stem Cells. 2006;8:319–334. [PubMed]
  • De Sousa PA, Gardner J, Sneddon S, et al. Clinically failed eggs as a source of normal human embryo stem cells. Stem Cell Res. 2009;2:188–197. [PubMed]
  • Beaujean N, Taylor J, Gardner J, et al. Effect of limited DNA methylation reprogramming in the normal sheep embryo on somatic cell nuclear transfer. Biol Reprod. 2004;71:185–193. [PubMed]
  • Koch P, Opitz T, Steinbeck JA, Ladewig J, Brüstle O. A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration. Proc Natl Acad Sci USA. 2009;106:3225–3230. [PMC free article] [PubMed]

Articles from Cell Research are provided here courtesy of Nature Publishing Group
PubReader format: click here to try


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Compound
    PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
  • Gene
    Gene records that cite the current articles. Citations in Gene are added manually by NCBI or imported from outside public resources.
  • GEO Profiles
    GEO Profiles
    Gene Expression Omnibus (GEO) Profiles of molecular abundance data. The current articles are references on the Gene record associated with the GEO profile.
  • HomoloGene
    HomoloGene clusters of homologous genes and sequences that cite the current articles. These are references on the Gene and sequence records in the HomoloGene entry.
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...